TABLE 2.

Effects of retigabine on membrane properties of SGNs

Rmp is resting membrane potential.

	Age	Base		Apex
		Control	Retigabine		Control	Retigabine
Spike number	2 weeks (n = 4)	29 ± 12	2 ± 1	n = 5	1 ± 0	0a
	3–4 months (n = 7)	20 ± 6	0.4 ± 0.5a	n = 8	1 ± 0	0a
	17 months (n = 5)	22 ± 6	1 ± 1a	n = 6	1 ± 0	0a
Rmp (mV)	2 weeks (n = 4)	−58 ± 2	−64 ± 1b	n = 5	−66 ± 4	−75 ± 5b
	3–4 months (n = 7)	−59 ± 3	−66 ± 3b	n = 8	−62 ± 2	−66 ± 3
	17 months (n = 5)	−59 ± 3	−69 ± 2a	n = 6	−61 ± 2	−67 ± 2b
AP duration (ms)	2 weeks (n = 4)	7 ± 1		n = 4	6 ± 2
	3–4 months (n = 7)	8 ± 2		n = 7	8 ± 1
	17 months (n = 5)	6 ± 2	3 ± 0a	n = 6	7 ± 1

^a p < 0.01 treatment versus control.

^b p < 0.05.